Your session is about to expire
← Back to Search
Impella-Supported PCI for Coronary Heart Disease (PROTECT IV Trial)
PROTECT IV Trial Summary
This trial will test if using a heart pump called Impella during high-risk heart procedures helps improve symptoms, heart function, and health better than the current standard of care.
PROTECT IV Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPROTECT IV Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PROTECT IV Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I had a severe heart attack between 1 to 30 days ago and my heart's pumping ability is very weak.I do not have severe heart, blood, or vascular conditions that would exclude me.I am between 18 and 90 years old.I have a specific type of heart blockage and plan to have surgery on it and two other areas.I have severe blockages in all three main heart arteries and plan to have stent placement in at least two.I had a severe heart attack within the last 24 hours or have complications from a heart attack.My heart team has recommended a procedure to open my heart's blocked arteries.I have a non-heart related condition that may shorten my life to under 3 years.I tested positive for COVID-19 recently but have not felt sick.My heart's pumping ability is reduced due to a recent heart attack.I had a heart or lung stoppage but have been stable and fully conscious for over 24 hours after being taken off a ventilator.I had COVID-19 symptoms or was hospitalized but have been symptom-free and back to my normal health for at least 4 weeks.I am currently in the hospital for COVID-19.I had a procedure on my last unblocked heart vessel.I have CCS or NSTEMI and my heart's pumping ability is 40% or less.I have severe blockages in the main arteries of my heart that need treatment.You are currently using a breathing tube, or have used one recently during your hospital stay.I can have an Impella device placed in my arteries without issues.I have experienced a severe heart condition known as cardiogenic shock.My heart team has recommended a procedure to open my heart's blocked arteries.I am scheduled for a complex heart procedure due to severe artery disease.I am scheduled for a complex PCI procedure.You must meet certain criteria related to your heart function.
- Group 1: Impella Arm
- Group 2: Control Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any opportunities to join this experiment at present?
"Clinicaltrials.gov confirms that this trial is actively recruiting participants from its initial posting on April 13th 2021 to the most recent update on November 16th 2022."
Does this trial take on subjects of legal majority age?
"According to the stated eligibility requirements, this clinical trial is open to participants who are between 18 and 90 years old. There are 25 studies for those under 18 and 597 studies available for seniors aged 65 or more."
Are there certain characteristics that would make an individual an ideal candidate for this experiment?
"This healthcare trial is seeking 1252 patients, aged 18 to 90, who have been diagnosed with coronary artery disease. Participants must meet the following criteria: Possession of certain clinical presentation and baseline left ventricular function parameters (2A or 2B), PCI has been deemed by a local heart team as the most suitable management option for them, Age between 18-90 years old, Intervention required in last remaining vessel (native coronary artery/bypass graft) OR Left main equivalent disease with both ostial LAD and LCX having visually assessed angiographic DS ≥80% [or ≥40% if there's non-invasive evidence"
How many individuals are currently enrolled in this clinical experiment?
"To complete this trial, 1252 subjects that meet the prerequisites must enroll. Individuals can sign up at Washington Regional Medical Center - Walker Heart Institute in Fayetteville, Arkansas and Metropolitan Heart and Vascular Institute / Metropolitan Cardiology Consultants in Coon Rapids, Minnesota."
How many medical facilities are actively conducting this experiment?
"Currently, 89 medical centres across the country are hosting this clinical trial. Among them are Fayetteville, Coon Rapids and Detroit along with other sites. To reduce commuting times for participants, it is advisable to select a nearby location when enrolling in the study."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger